DECREASED in vitro TYPE 1 IMMUNE RESPONSE AGAINST COXSACKIE VIRUS B4 IN CHILDREN WITH TYPE 1 DIABETES
スポンサーリンク
概要
- 論文の詳細を見る
- 2005-10-01
著者
-
Holmberg Hanna
Division Of Paediatrics And Diabetes Research Centre Department Of Molecular And Clinical Medicine L
-
Ilonen Jorma
Jdrf Center For Prevention Of Type 1 Diabetes In Finland At The Universities Of Turku
-
Ilonen Jorma
Turku Immunology Centre And Department Of Virology University Of Turku
-
ILONEN Jorma
University of Turku
-
VAARALA Outi
National Public Health Institute
-
HONKANEN Jarno
Department of Viral Diseases and Immunology, National Public Health Institute
-
Vaarala Outi
Division Of Paediatrics And Diabetes Research Centre Department Of Molecular And Clinical Medicine L
-
Vaarala Outi
University Of Linkoping
-
Vaarala Outi
Department Of Viral Diseases And Immunology National Public Health Institute
-
Honkanen Jarno
Department Of Viral Diseases And Immunology National Public Health Institute
-
Skarsvik Susanne
Division Of Pediatrics And Diabetes Research Centre Department Of Molecular And Clinical Medicine Li
-
PURANEN Julia
Division of Pediatrics and Diabetes Research Centre, Department of Molecular and Clinical Medicine,
-
ROIVAINEN Merja
Enterovirus Laboratory, Department of Viral Diseases and Immunology, National Public Health Institut
-
LUDVIGSSON Johnny
Division of Pediatrics and Diabetes Research Centre, Department of Molecular and Clinical Medicine,
-
Puranen Julia
Division Of Pediatrics And Diabetes Research Centre Department Of Molecular And Clinical Medicine Li
-
Roivainen Merja
Enterovirus Laboratory Department Of Viral Diseases And Immunology National Public Health Institute
-
Ludvigsson Johnny
Division Of Paediatrics And Diabetes Research Centre Department Of Molecular And Clinical Medicine L
-
Ludvigsson Johnny
University Of Linkoping
関連論文
- DIETARY INSULIN AS AN IMMUNOGEN AND TOLEROGEN
- POOR IN VITRO INDUCTION OF Treg CELLS IN TYPE 1 CYTOKINE ENVIRONMENT IN CHILDREN WITH RECENTLY DIAGNOSED TYPE 1 DIABETES
- FEASIBILITY OF A PLACEBO-CONTROLLED DOUBLE-BLINDED TYPE 1 DIABETES (T1D) PREVENTION TRIAL TESTING EFFICACY OF NASAL INSULIN IN A POPULATION-BASED COHORT OF CHILDREN WITH HLA-CONFERRED T1D RISK AND MULTIPLE AUTOANTIBODIES
- ENTEROVIRUS ANALYSES FROM PANCREATIC TISSUE OF A CHILD POSITIVE FOR DIABETES-ASSOCIATED AUTOANTIBODIES
- ANALYSIS OF REGULATORY CD4^+CD25^ T-CELLS AND NATURAL KILLER T-CELLS IN CHILDREN WITH NEWLY DIAGNOSED TYPE 1 DIABETES AND IN AUTOANTIBODY-POSITIVE SUBJECTS
- PTPN22 LYMPHOID TYROSINE PHOSPHATASE Arg620Trp VARIANT REGULATES INSULIN AUTOIMMUNITY AND PROGRESSION TO TYPE 1 DIABETES
- ENHANCED T-CELL REACTIVITY TO INSULIN PEPTIDE A1-12 IN CHILDREN WITH RECENTLY DIAGNOSED TYPE 1 DIABETES OR DIABETES ASSOCIATED AUTOANTIBODIES
- TEMPORAL SEASONALITY IN EMERGENCE OF DIABETES-ASSOCIATED AUTOANTIBODIES IN CHILDREN
- THE RATE OF EMERGENCE OF AUTOANTIBODIES IS STABLE BETWEEN 6 MONTHS AND AT LEAST 8 YEARS OF AGE BUT DEPENDS ON HLA-CONFERRED RISK IN A PROSPECTIVELY FOLLOWED-UP POPULATION-BASED BIRTH COHORT
- DECREASED in vitro TYPE 1 IMMUNE RESPONSE AGAINST COXSACKIE VIRUS B4 IN CHILDREN WITH TYPE 1 DIABETES
- SHORT DURATION OF BREASTFEEDING AS A RISK-FACTOR FOR BETA-CELL AUTOANTIBODIES IN FIVE-YEAR-OLD HEALTHY CHILDREN
- PROBIOTICS FOR THE PREVENTION OF BETA-CELL AUTOIMMUNITY IN CHILDREN AT GENETIC RISK OF TYPE 1 DIABETES - PRODIA STUDY
- ATOPIC SYMPTOMS AND BETA-CELL AUTOIMMUNITY DURING THE FIRST TWO YEARS OF LIFE